The Canadian National Vaccine Safety Network: surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada

• Gaston De Serres,
• Manish Sadarangani,
• Karina A Top,
• James D Kellner,
• Allison McGeer,
• Louis Valiquette,
• Julie A Bettinger,
• Otto G Vanderkooi,
• Matthew P Muller,
• Jennifer E Isenor,
• Kimberly Marty

Affiliations

Gaston De Serres

Institut national de sante publique du Quebec, Quebec, Quebec, Canada

Manish Sadarangani

2 Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada

Karina A Top

Canadian Center for Vaccinology, Dalhousie University, Halifax, Nova Scotia, Canada

James D Kellner

Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Allison McGeer

Department of Microbiology, Mount Sinai Hospital, Toronto, Ontario, Canada

Louis Valiquette

Department of Microbiology and Infectiology, Centre Intégré Universitaire de Santé et de Services Sociaux de l’Estrie – Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada

Julie A Bettinger

Vaccine Evaluation Center, BC Children’s Hospital Research Institute, Vancouver, British Columbia, Canada

Otto G Vanderkooi

Alberta Children’s Hospital Research Institute, Calgary, Alberta, Canada

Matthew P Muller

Medicine, Unity Health Toronto, Toronto, Ontario, Canada

Jennifer E Isenor

Canadian Center for Vaccinology, Dalhousie University, Halifax, Nova Scotia, Canada

Kimberly Marty

Vaccine Evaluation Center, BC Children’s Hospital Research Institute, Vancouver, British Columbia, Canada